FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105252425> ?p ?o ?g. }

• W2105252425 endingPage "115" @default.
• W2105252425 startingPage "106" @default.
• W2105252425 abstract "Successful development and use of biomarkers will improve the productivity of oncology drug development. Recognition of the importance of biomarkers for speeding drug development is reflected in the precise definitions and concepts proposed by an NIH Working Group to standardize terminology and promote a more coherent and systematic approach to the development and use of biomarkers. Potential clinical biomarkers of drug efficacy are often identified through pre-clinical studies or basic research. Identification of potential biomarkers for use in oncology is moving rapidly forward through continuing advances in clinical imaging technologies, especially molecular and functional imaging. Other rapid advances are a product of the growing availability of new scientific reagents for established technologies and of high-throughput genomic and proteomic technologies that can generate hundreds of potential biomarkers for further evaluation. In certain cases, conventional clinical diagnostic techniques or assays can be adapted for use in pre-clinical models to evaluate their ability to serve as biomarkers for predicting clinical responses to new drug candidates. Evaluation (pre-clinical and clinical) of a potential biomarker is often the longest stage of biomarker development, and standards for evaluation or validation depend on the intended use and stage of clinical development. Biomarkers verified for use in preclinical studies can be used to help select appropriate animal models and lead compounds. Biomarkers verified for use in clinical trials can confirm a drug's pharmacological or biological mechanism of action, guide protocol design, aid patient and dose selection, and help to minimize safety risks. Oncology drug development can be optimized by using a tiered set of clinical biomarkers that predict compound efficacy and safety with increasing confidence at each rise in tier thereby aiding corporate decision-making about advancing compounds. In oncology, a special class of extensively evaluated biomarkers of efficacy (surrogate endpoints) that generally correlate with desired clinical outcomes can be used as a basis for corporate decisions as well as for gaining accelerated provisional regulatory approval of a drug." @default.
• W2105252425 created "2016-06-24" @default.
• W2105252425 creator A5056342567 @default.
• W2105252425 creator A5059801663 @default.
• W2105252425 date "2004-01-01" @default.
• W2105252425 modified "2023-10-18" @default.
• W2105252425 title "Development and Use of Biomarkers in Oncology Drug Development" @default.
• W2105252425 cites W101078660 @default.
• W2105252425 cites W113961648 @default.
• W2105252425 cites W1492536054 @default.
• W2105252425 cites W1537149667 @default.
• W2105252425 cites W1551070020 @default.
• W2105252425 cites W1561712812 @default.
• W2105252425 cites W1787102412 @default.
• W2105252425 cites W1797956629 @default.
• W2105252425 cites W1844712574 @default.
• W2105252425 cites W1845552116 @default.
• W2105252425 cites W1967696143 @default.
• W2105252425 cites W1969889522 @default.
• W2105252425 cites W1973294865 @default.
• W2105252425 cites W1983665434 @default.
• W2105252425 cites W1989790390 @default.
• W2105252425 cites W1993860023 @default.
• W2105252425 cites W1996265792 @default.
• W2105252425 cites W2000980666 @default.
• W2105252425 cites W2003407908 @default.
• W2105252425 cites W2007477730 @default.
• W2105252425 cites W2010444010 @default.
• W2105252425 cites W2011823981 @default.
• W2105252425 cites W2013707964 @default.
• W2105252425 cites W2019124674 @default.
• W2105252425 cites W2039633811 @default.
• W2105252425 cites W2054266788 @default.
• W2105252425 cites W2059313996 @default.
• W2105252425 cites W2065977830 @default.
• W2105252425 cites W2069085828 @default.
• W2105252425 cites W2070318660 @default.
• W2105252425 cites W2081199973 @default.
• W2105252425 cites W2085274874 @default.
• W2105252425 cites W2089531514 @default.
• W2105252425 cites W2098629569 @default.
• W2105252425 cites W2099035017 @default.
• W2105252425 cites W2099882614 @default.
• W2105252425 cites W2100869063 @default.
• W2105252425 cites W2104389711 @default.
• W2105252425 cites W2104586902 @default.
• W2105252425 cites W2104753628 @default.
• W2105252425 cites W2105567764 @default.
• W2105252425 cites W2116991201 @default.
• W2105252425 cites W2117135012 @default.
• W2105252425 cites W2119507443 @default.
• W2105252425 cites W2120018526 @default.
• W2105252425 cites W2120909504 @default.
• W2105252425 cites W2121046005 @default.
• W2105252425 cites W2121175754 @default.
• W2105252425 cites W2122760299 @default.
• W2105252425 cites W2123507042 @default.
• W2105252425 cites W2130002616 @default.
• W2105252425 cites W2131181434 @default.
• W2105252425 cites W2135358937 @default.
• W2105252425 cites W2139248078 @default.
• W2105252425 cites W2143345040 @default.
• W2105252425 cites W2146595692 @default.
• W2105252425 cites W2147117661 @default.
• W2105252425 cites W2148532893 @default.
• W2105252425 cites W2148782878 @default.
• W2105252425 cites W2150027485 @default.
• W2105252425 cites W2154270341 @default.
• W2105252425 cites W2155470210 @default.
• W2105252425 cites W2156767742 @default.
• W2105252425 cites W2161240017 @default.
• W2105252425 cites W2161559302 @default.
• W2105252425 cites W2161723120 @default.
• W2105252425 cites W2162525969 @default.
• W2105252425 cites W2166478128 @default.
• W2105252425 cites W2167917163 @default.
• W2105252425 cites W2169741256 @default.
• W2105252425 cites W2169929983 @default.
• W2105252425 cites W2171034841 @default.
• W2105252425 cites W2171376926 @default.
• W2105252425 cites W2409615753 @default.
• W2105252425 cites W2803327664 @default.
• W2105252425 cites W28497082 @default.
• W2105252425 cites W4234346992 @default.
• W2105252425 cites W4240064739 @default.
• W2105252425 cites W4242434902 @default.
• W2105252425 cites W4255723385 @default.
• W2105252425 cites W85078242 @default.
• W2105252425 cites W91108901 @default.
• W2105252425 cites W99080988 @default.
• W2105252425 doi "https://doi.org/10.1080/01926230490425021" @default.
• W2105252425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15209410" @default.
• W2105252425 hasPublicationYear "2004" @default.
• W2105252425 type Work @default.
• W2105252425 sameAs 2105252425 @default.
• W2105252425 citedByCount "55" @default.
• W2105252425 countsByYear W21052524252012 @default.
• W2105252425 countsByYear W21052524252013 @default.

• next